Disruption of gut bacteria early in life can lead to obesity in adulthood
"We identified infancy as a critical window where host metabolism is especially vulnerable to microbiota disruption with antibiotics," says senior study author Martin Blaser of the NYU Langone Medical Center. "This highlights a need for judicious use of antibiotics in clinical practice in early life."
Microbes begin to colonize the gut at birth, and disruption of these communities with antibiotics early in life can have long-term effects on weight. Farmers have been taking advantage of this phenomenon for decades by exposing livestock to low doses of antibiotics to promote growth. Blaser and his team wanted to examine whether the exact timing and duration of early exposure to antibiotics could make a difference, as well as identify specific bacteria that may protect against the potentially harmful health effects.
To address these questions, the researchers gave long-term, low-dose penicillin treatment to two groups of mice: 4-week-old mice after weaning and mouse mothers beginning shortly before their pups' birth. They found that earlier penicillin exposure led to more substantial obesity in adulthood and worse metabolic health, especially in males. Early exposure to antibiotics also reduced levels of several types of potentially protective bacteria and exacerbated the effects of a high-fat diet on obesity. In a separate experiment, the researchers found that only 4 weeks of antibiotic exposure beginning shortly before birth was sufficient to produce obesity, which lasted well after penicillin treatment ended.
Moreover, the researchers demonstrated that altered gut microbes rather than antibiotics per se caused these metabolic changes: "Our findings imply that restoring good bacteria could prevent the long-term metabolic effects of early antibiotic exposure," says lead study author Laura Cox of the NYU Langone Medical Center. "We identified four candidate bacteria that may be metabolically protective, and we're working on follow-up studies to determine if we can prevent weight gain by giving these bacteria back following antibiotic therapy."
Original publication
Cell, Cox et al.: "Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.